Apathy and anhedonia are often confused with each other and sometimes used interchangeably, but they describe different problems. Apathy is primarily a loss of motivation: the drive to start, plan, or care about activities drops away. Anhedonia is a loss of pleasure: activities that once felt rewarding no longer produce enjoyment or satisfaction. A person with apathy might not bother going to a concert; a person with anhedonia might go to the concert but feel nothing while there. In practice, these two states overlap frequently enough that untangling them has been a genuine challenge for clinicians and researchers alike.
What Each One Actually Feels Like
Apathy shows up as a kind of motivational emptiness. You know you should do things, you might even know you’d benefit from doing them, but the internal push to act simply isn’t there. It affects everything from getting off the couch to engaging in conversation to planning your week. People with apathy often describe a flatness in how they relate to the world: not sadness, not frustration, just a pervasive “I don’t care.” The emotional coloring of daily life fades, and the person may not even be bothered by that fact, which is part of what makes apathy so tricky to recognize.
Anhedonia, by contrast, preserves motivation in some cases but strips away the payoff. You go through the motions of eating your favorite meal, spending time with friends, or watching a movie you’ve been looking forward to, and the experience lands flat. The pleasure circuitry that would normally light up simply doesn’t fire the way it used to. One clinical description captures it well: anhedonia is a state in which a person’s sensitivity to pleasure has decreased, such that behaviors and activities that were once joyfully performed no longer produce that same reward.1PubMed Central. Apathy and Anhedonia in Parkinson’s Disease
The distinction matters because the subjective experience guides different treatment strategies. Someone who lacks the drive to act needs a different kind of help than someone who acts but feels nothing. Yet many people experience both simultaneously, and most clinical questionnaires have not historically been designed to separate them cleanly. A large analysis across seven datasets, totaling over 4,500 participants, used factor analysis and machine learning to demonstrate that apathy, anhedonia, and depression consistently emerged as distinct syndromes, each identifiable by a core set of symptoms, even when two or all three co-occurred in the same person.2JNNP / BMJ Group. On the relationships between apathy, depression and anhedonia
Anhedonia Is Not Simply “Feeling No Pleasure”
For a long time, anhedonia was understood as a straightforward inability to enjoy things. But research over the past decade and a half has complicated this picture in a useful way. Pleasure involves at least two stages: the anticipation of something rewarding (sometimes called “wanting”) and the actual experience of consuming or doing the rewarding thing (“liking”). These turn out to be separable, and they can break down independently.
A recent study comparing people with major depression to healthy controls found something surprising. When participants actually tasted food they had chosen, those with depression rated their enjoyment at the same level as everyone else. The difference showed up earlier, in the anticipation phase: people with depression reported lower wanting for the food before they received it, roughly five points lower on a 100-point scale. Once they were actually eating, the gap disappeared.3Cell Reports Medicine. Phenotype-specific metabolic alterations and blunted anticipatory wanting characterize reward processing in major depressive disorder Scores on a standard anhedonia questionnaire were also linked to reduced wanting during anticipation but not to reduced liking during consumption, reinforcing the idea that what clinicians call anhedonia in depression is often a deficit in looking forward to rewards rather than an inability to enjoy them once they arrive.
This wanting-versus-liking split has practical implications. If your version of anhedonia is mainly anticipatory, you might benefit from strategies that rebuild the capacity to look forward to things. If it is consummatory, the interventions look different. Some treatments target one component more than the other: dopamine-enhancing medications tend to address motivational blunting, while mindfulness or savoring-based therapies aim more at the in-the-moment pleasure side.4PubMed Central. Anhedonia: Current and future treatments
Apathy Has Multiple Dimensions Too
Just as anhedonia is more complex than “no pleasure,” apathy is more than just laziness or indifference. Researchers have identified at least three sub-domains of apathy: behavioral (reduced self-initiated action), cognitive (reduced planning, goal-setting, and curiosity), and emotional or affective (diminished emotional responsiveness). A study of people with acquired brain injury found that these three sub-domains had different relationships with cognitive performance. Global apathy scores, lumping everything together, did not predict how someone performed on neuropsychological tests. But when the sub-domains were examined separately, cognitive apathy was linked to executive function problems, and the three dimensions differed in their connection to emotion recognition.5Frontiers in Neurology. Distinct Neuropsychological Correlates of Cognitive, Behavioral, and Affective Apathy Sub-Domains in Acquired Brain Injury
The large factor-analysis study mentioned earlier confirmed this structure outside of brain injury too: when depression, anhedonia, and apathy symptoms were analyzed together across healthy people and those with major depressive disorder, apathy reliably separated into three factors (behavioral, social, and emotional), distinct from both depression and anhedonia.2JNNP / BMJ Group. On the relationships between apathy, depression and anhedonia Someone might have strong emotional apathy (nothing seems to move them) while retaining decent behavioral initiative, or vice versa. Treating apathy as a single monolithic thing misses these differences.
Overlapping but Distinct Brain Circuits
Both apathy and anhedonia involve disruption to the brain’s reward and motivation networks, which is one reason they so often co-occur. But the specific patterns of disruption differ, and those differences are becoming clearer as neuroimaging research accumulates.
For apathy, the most consistent finding across multiple neurological conditions is altered function in circuits connecting the frontal cortex and the striatum, a deep brain region involved in action selection and reward processing. The ventral striatum and portions of the anterior cingulate cortex, a region involved in weighing effort against reward, emerge as the core nodes. Damage or dysfunction at any point in this loop can produce apathetic behavior.6PubMed Central. The anatomy of apathy: A neurocognitive framework for amotivated behaviour The specific brain region most strongly associated with apathy can vary by disease: in Alzheimer’s disease, dysfunction of the anterior cingulate cortex is the strongest correlate, while in cerebrovascular disorders like stroke, lesions of the basal ganglia are more commonly implicated.7PubMed. The neuroimaging basis of apathy: Empirical findings and conceptual challenges
For anhedonia, the picture centers on a partially overlapping but functionally distinct set of circuits. The severity of anhedonia is associated with reduced activity in the ventral striatum (including the nucleus accumbens, a key node for processing reward) and excessive activity in parts of the ventral prefrontal cortex, with dopamine playing a central but not exclusive role.8PubMed Central. Neurobiological mechanisms of anhedonia Broader disruptions in the mesocortical and mesolimbic dopamine systems, which carry reward-related signals between the midbrain and the cortex, have been proposed as a shared neurobiological basis for anhedonia across both depression and schizophrenia.9PubMed Central. Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits
So both conditions involve the striatum and frontal cortex, but apathy appears to be more about the circuit that decides whether an action is worth the effort, while anhedonia is more about the circuit that assigns value and pleasure to outcomes. They are neighbors in the brain, connected by shared dopaminergic pathways, which explains why they so often travel together.
How They Show Up in Parkinson’s Disease
Parkinson’s disease is one of the clearest windows into how apathy and anhedonia can be studied as distinct phenomena, because both are common in Parkinson’s yet have somewhat different profiles. A meta-analysis covering over 5,300 patients found that apathy affects about 40% of people with Parkinson’s. It correlates with older age, greater motor impairment, lower cognitive scores, and more severe disability. About half of Parkinson’s patients with apathy also have depression, but the other half do not, confirming that apathy in Parkinson’s stands on its own as a separate clinical syndrome.10PubMed. Apathy in Parkinson’s disease: A systematic review and meta-analysis
Apathy in Parkinson’s is often subtle and easy to miss. Patients and caregivers may attribute the lack of initiative to physical limitations or fatigue rather than recognizing it as a neuropsychiatric symptom in its own right.11PubMed Central. Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology Anhedonia in Parkinson’s, meanwhile, tends to be studied alongside apathy but is measured differently. The progressive loss of dopamine neurons that defines Parkinson’s disease provides a natural experiment in what happens when the brain’s motivation and reward chemistry erodes, and both symptoms may reflect different downstream consequences of the same underlying dopamine depletion.12PubMed. Prevalence and clinical correlates of apathy in Parkinson’s disease: a community-based study
The Schizophrenia Angle
In schizophrenia, both apathy and anhedonia fall under the umbrella of “negative symptoms,” a cluster of deficits that represent the absence of normal functioning rather than the presence of abnormal experiences like hallucinations. A consensus in the field has settled on five core negative symptoms: blunted affect, alogia (poverty of speech), anhedonia, avolition (lack of will or initiative, essentially the behavioral side of apathy), and asociality. These five group into two factors: one involving expressive deficits (blunted affect and alogia) and the other involving motivation and pleasure deficits (anhedonia, avolition, and asociality).13PubMed Central. The current conceptualization of negative symptoms in schizophrenia
The fact that anhedonia and avolition cluster together in schizophrenia research underscores how tightly these constructs are woven. Assessment work in animal models and clinical studies has emphasized that reward anticipation deficits may be especially relevant: people with schizophrenia often retain the capacity to enjoy pleasant stimuli in the moment but show reduced ability to anticipate or pursue rewards, paralleling the wanting-versus-liking findings in depression.14PubMed Central. Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia
Different Dementia Types, Different Apathy Profiles
Apathy is extremely common in dementia, but its flavor differs depending on the type. In Alzheimer’s disease, about 60% of patients show some degree of apathy, while in behavioral-variant frontotemporal dementia (bvFTD), the figure climbs to around 84%, with more severe and more frequent symptoms. The profile also differs: bvFTD patients tend to show higher emotional and cognitive apathy, while Alzheimer’s patients show primarily cognitive apathy.15Cortex. Apathy in Alzheimer’s disease and frontotemporal dementia: Distinct clinical profiles and neural correlates
These differences evolve over time. Early in the disease course, emotional apathy is more prominent in bvFTD than in Alzheimer’s. Later on, Alzheimer’s patients show greater executive apathy, the kind involving planning and goal-directed behavior, though all dimensions of apathy are elevated compared to healthy older adults by that stage.16PubMed. Disease-specific profiles of apathy in Alzheimer’s disease and behavioural-variant frontotemporal dementia differ across the disease course Brain imaging confirms distinct anatomical underpinnings: apathy in bvFTD involves frontal and insular cortical areas, while in Alzheimer’s it is more closely tied to the right anterior cingulate cortex.17PubMed. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer’s disease For caregivers, this matters. The apathy you see in someone with bvFTD early on, where they seem emotionally unreachable, is a different animal from the apathy in Alzheimer’s, where the person may struggle more with initiating and organizing tasks.
When Antidepressants Cause the Problem
One of the more frustrating clinical scenarios involves medications that are supposed to help with depression inadvertently producing apathy or emotional blunting. SSRIs, the most commonly prescribed class of antidepressants, have been associated with a syndrome sometimes called SSRI-induced indifference, which combines features of both behavioral apathy and emotional flattening under a single umbrella.18PubMed Central. SSRI-Induced Indifference
Estimates of how often this happens vary widely. A systematic review found that the reported prevalence of antidepressant-induced apathy ranges from about 6% to 50% across studies, and for SSRIs specifically, figures range from 20% to as high as 92%. The syndrome appears dose-dependent and reversible: it emerges independently of diagnosis, age, and whether the antidepressant is otherwise working, and it tends to improve when the dose is reduced or the medication is changed.19Acta Neuropsychiatrica. Apathy associated with antidepressant drugs: a systematic review If you’re on an SSRI and find that your depression has lifted but you feel emotionally flat or unmotivated, this is a known side effect worth bringing up with your prescriber, not just what depression “feels like when treated.”
How Clinicians Measure Each One
Separate measurement tools exist for apathy and anhedonia, which reflects the field’s recognition that they need different assessment approaches. For apathy, the most widely studied instrument is the Apathy Evaluation Scale (AES), which has been validated across brain injury, Alzheimer’s disease, multiple sclerosis, and severe mental illness populations.20PubMed Central. Clinical utility and psychometric properties of the Apathy Evaluation Scale A systematic review of apathy scales in neurodegenerative conditions found the AES clinical version and the Lille Apathy Rating Scale to be among the strongest psychometrically.21International Psychogeriatrics. A systematic review of the validity and reliability of apathy scales in neurodegenerative conditions For specific populations, different tools perform better: the Dementia Apathy Interview and Rating for Alzheimer’s patients, and the Positive and Negative Symptom Scale for people with schizophrenia.22PubMed Central. Are the available apathy measures reliable and valid? A review of the psychometric evidence
For anhedonia, the Snaith-Hamilton Pleasure Scale (SHAPS) has been the workhorse for decades, measuring hedonic capacity through items about everyday pleasures. Newer tools like the New York Scale of Anhedonia have been developed to capture additional dimensions, including social anhedonia, and show good validity against the SHAPS.23Archives of Psychiatry and Psychotherapy. The New York Scale of Anhedonia: Development and Validation of a New Measure The proliferation of separate scales for each construct has been important practically, because older depression questionnaires tended to lump motivational and pleasure-related items together, making it impossible to tell whether a high score reflected apathy, anhedonia, depressed mood, or some combination.
Effort-Based Decision-Making as a Research Tool
One of the more creative approaches to distinguishing apathy from anhedonia experimentally uses tasks that require people to decide whether a reward is worth a certain amount of effort. The logic is that apathy should reduce willingness to exert effort for any reward, while anhedonia should reduce how appealing the reward seems. A study of adolescent girls with depression used computational modeling of these effort-based decisions and found that in healthy controls, higher apathy was associated with lower rates of accepting effortful tasks, while anhedonia showed no such relationship. In the depression group, neither symptom predicted task acceptance, suggesting the picture gets muddier when both conditions are actively present.24PubMed. Computational modelling of effort-based decision-making in depression: The role of apathy and anhedonia in adolescent girls Effort tasks like these are helping researchers develop more precise behavioral markers for each construct, which may eventually improve diagnosis.
Aging and the Erosion of Reward Sensitivity
Both apathy and anhedonia become more common with age, even outside of any diagnosed disease. Older adults show reduced brain activity in the striatum during anticipation of rewards, impaired learning of reward associations, and well-documented age-related declines in dopamine function.25PubMed Central. Inhibitory Control and Reward Responsiveness in Healthy Aging These changes can manifest as mild apathy or anhedonia that falls below the threshold for any clinical diagnosis but still affects quality of life: the retired person who finds nothing interesting anymore, the grandparent who used to love cooking but can’t muster the enthusiasm. Whether this is “normal aging” or a subclinical form of the same processes that produce apathy and anhedonia in neurological disease remains an open question. What is clear is that the dopaminergic declines underlying both states are a shared feature of the aging brain, and recognizing mild forms early may matter for maintaining engagement and wellbeing in later life.